We believe that our study makes a significant contribution to the literature because our results suggest that the p53/PAI-1 signaling axis may participate in AF and SERPINE1 (PAI-1) may serve as a new therapeutic AF biomarker. The gene discussed is SERPINE1; the disease is atrial fibrillation.